Treating C3 glomerulopathy with eculizumab

T Welte, F Arnold, J Kappes, M Seidl, K Häffner… - BMC nephrology, 2018 - Springer
Abstract Background C3 glomerulopathy (C3G) is a rare, but severe glomerular disease with
grim prognosis. The complex pathogenesis is just unfolding, and involves acquired as well …

Proliferative glomerulonephritis secondary to dysfunction of the alternative pathway of complement

S Sethi, FC Fervenza, Y Zhang, SH Nasr… - Clinical Journal of the …, 2011 - journals.lww.com
Results Evidence of AP activation was demonstrable in all cases and included increased
levels of soluble membrane attack complex (all cases), positive AP functional assays (four …

[HTML][HTML] Atypical postinfectious glomerulonephritis is associated with abnormalities in the alternative pathway of complement

S Sethi, FC Fervenza, Y Zhang, L Zand, NC Meyer… - Kidney international, 2013 - Elsevier
Postinfectious glomerulonephritis is a common disorder that develops following an infection.
In the majority of cases, there is complete recovery of renal function within a few days to …

Anti-factor B and anti-C3b autoantibodies in C3 glomerulopathy and Ig-associated membranoproliferative GN

MC Marinozzi, LT Roumenina, S Chauvet… - Journal of the …, 2017 - journals.lww.com
Abstract In C3 glomerulopathy (C3G), the alternative pathway of complement is frequently
overactivated by autoantibodies that stabilize the C3 convertase C3bBb. Anti-C3b and anti …

The role of complement in C3 glomerulopathy

PF Zipfel, C Skerka, Q Chen, T Wiech, T Goodship… - Molecular …, 2015 - Elsevier
C3 glomerulopathy describes a spectrum of disorders with glomerular pathology associated
with C3 cleavage product deposition and with defective complement action and regulation …

Pathogenesis of the C3 glomerulopathies and reclassification of MPGN

AS Bomback, GB Appel - Nature Reviews Nephrology, 2012 - nature.com
Until recently, membranoproliferative glomerulonephritis (MPGN) was clinically classified as
either primary, idiopathic MPGN or as secondary MPGN when an underlying aetiology was …

[HTML][HTML] Dense deposit disease and C3 glomerulopathy

TD Barbour, MC Pickering, HT Cook - Seminars in nephrology, 2013 - Elsevier
C3 glomerulopathy refers to those renal lesions characterized histologically by predominant
C3 accumulation within the glomerulus, and pathogenetically by aberrant regulation of the …

C3 glomerulopathy: clinicopathologic features and predictors of outcome

NR Medjeral-Thomas… - Clinical Journal of the …, 2014 - journals.lww.com
Results Eighty patients with C3 glomerulopathy were identified: 21 with DDD and 59 with
C3GN. Patients with DDD were younger, more likely to have low serum C3 levels, and more …

[HTML][HTML] Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies

A Servais, LH Noël, LT Roumenina, M Le Quintrec… - Kidney international, 2012 - Elsevier
Dense deposit disease and glomerulonephritis with isolated C3 deposits are
glomerulopathies characterized by deposits of C3 within or along the glomerular basement …

[HTML][HTML] C5 nephritic factors drive the biological phenotype of C3 glomerulopathies

MC Marinozzi, S Chauvet, M Le Quintrec, M Mignotet… - Kidney international, 2017 - Elsevier
C3 Glomerulopathies, which include Dense Deposit Disease and C3 Glomerulonephritis,
are associated with genetic and acquired dysregulation of the C3 convertase alternative …